Cerus Corp. (NASDAQ:CERS)’s share price was down 1.5% during mid-day trading on Thursday . The company traded as low as $6.69 and last traded at $6.70, with a volume of 540,917 shares changing hands. The stock had previously closed at $6.80.

Several equities analysts have recently weighed in on the stock. BTIG Research restated a “buy” rating and set a $10.00 price objective (up previously from $8.00) on shares of Cerus Corp. in a research report on Friday, April 22nd. Zacks Investment Research lowered shares of Cerus Corp. from a “hold” rating to a “sell” rating in a research report on Tuesday, August 9th. Cantor Fitzgerald restated a “buy” rating and set a $9.00 price objective on shares of Cerus Corp. in a research report on Sunday, July 31st. FBR & Co restated an “outperform” rating and set a $10.00 price objective on shares of Cerus Corp. in a research report on Thursday, August 11th. Finally, Robert W. Baird restated an “outperform” rating and set a $9.00 price objective on shares of Cerus Corp. in a research report on Wednesday, June 22nd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $9.10.

The company’s 50 day moving average price is $6.71 and its 200-day moving average price is $6.01. The stock’s market capitalization is $694.31 million.

Cerus Corp. (NASDAQ:CERS) last issued its quarterly earnings data on Thursday, August 4th. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.17) by $0.01. During the same period in the previous year, the firm posted ($0.17) earnings per share. The business earned $9.25 million during the quarter, compared to the consensus estimate of $8.88 million. The business’s revenue for the quarter was up 4.8% on a year-over-year basis. On average, equities research analysts predict that Cerus Corp. will post ($0.68) EPS for the current fiscal year.

A hedge fund recently raised its stake in Cerus Corp. stock. Rail Splitter Capital Management LLC increased its position in shares of Cerus Corp. (NASDAQ:CERS) by 19.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 832,722 shares of the company’s stock after buying an additional 132,970 shares during the period. Rail Splitter Capital Management LLC owned 0.86% of Cerus Corp. worth $5,263,000 as of its most recent SEC filing.

Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.